FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048060527> ?p ?o ?g. }

• W3048060527 endingPage "479" @default.
• W3048060527 startingPage "466" @default.
• W3048060527 abstract "Objective To evaluate the current literature for tisagenlecleucel in the treatment of relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (ALL). Data Sources A literature search of PubMed (inception to June 18, 2020) and ClinicalTrials.gov was conducted using the following search terms: CTL019, chimeric antigen receptor, CAR-T, and tisagenlecleucel. Study Selection and Data Extraction All trials evaluating the use of tisagenlecleucel in B-cell ALL were reviewed and considered for inclusion. Data Synthesis Tisagenlecleucel displayed overall remission rates ranging from 69% to 93% in patients who historically respond extremely poorly to salvage therapy. Remissions were durable, with 12-month relapse-free survival (RFS) rates of 55% to 59%. These promising results are tempered by the unique adverse effect profile of chimeric antigen receptor (CAR) T-cell therapy. Potentially life-threatening cytokine release syndrome (CRS) occurred in 77% to 100% of patients, and immune effector cell–associated neurotoxicity syndrome (ICANS) developed in 31% to 45% of patients receiving tisagenlecleucel. Relevance to Patient Care and Clinical Practice The successful utilization of tisagenlecleucel therapy requires meticulous planning, prudent patient selection, multidisciplinary collaboration, and expert training to ensure optimal patient care. The complex interplay of patient- and treatment-related factors creates problematic barriers that must be expertly navigated by the health care team and authorized treatment center. Conclusions As the first US Food and Drug Administration–approved gene therapy, tisagenlecleucel heralds an immunotherapeutic breakthrough for treating pediatric and young adult patients with r/r B-cell ALL. Many questions surrounding patient-specific gene and cellular therapies remain, but their transformative potential in cancer care remains promising." @default.
• W3048060527 created "2020-08-13" @default.
• W3048060527 creator A5020006994 @default.
• W3048060527 creator A5029013002 @default.
• W3048060527 creator A5065535291 @default.
• W3048060527 creator A5073018865 @default.
• W3048060527 date "2020-08-07" @default.
• W3048060527 modified "2023-09-23" @default.
• W3048060527 title "Tisagenlecleucel in Acute Lymphoblastic Leukemia: A Review of the Literature and Practical Considerations" @default.
• W3048060527 cites W1558704041 @default.
• W3048060527 cites W1767113662 @default.
• W3048060527 cites W1801876107 @default.
• W3048060527 cites W1972297696 @default.
• W3048060527 cites W1987446594 @default.
• W3048060527 cites W1988623079 @default.
• W3048060527 cites W2000297273 @default.
• W3048060527 cites W2005501262 @default.
• W3048060527 cites W2008009748 @default.
• W3048060527 cites W2010607826 @default.
• W3048060527 cites W2015526806 @default.
• W3048060527 cites W2023761225 @default.
• W3048060527 cites W2050056063 @default.
• W3048060527 cites W2051646706 @default.
• W3048060527 cites W2072434377 @default.
• W3048060527 cites W2082708772 @default.
• W3048060527 cites W2085533078 @default.
• W3048060527 cites W2104187048 @default.
• W3048060527 cites W2105400883 @default.
• W3048060527 cites W2118796952 @default.
• W3048060527 cites W2119770188 @default.
• W3048060527 cites W2130011407 @default.
• W3048060527 cites W2136453261 @default.
• W3048060527 cites W2136627573 @default.
• W3048060527 cites W2141410122 @default.
• W3048060527 cites W2142300779 @default.
• W3048060527 cites W2151246207 @default.
• W3048060527 cites W2155250860 @default.
• W3048060527 cites W2160881482 @default.
• W3048060527 cites W2325322965 @default.
• W3048060527 cites W2419639370 @default.
• W3048060527 cites W2519710256 @default.
• W3048060527 cites W2529226476 @default.
• W3048060527 cites W2592081641 @default.
• W3048060527 cites W2754562068 @default.
• W3048060527 cites W2760653955 @default.
• W3048060527 cites W2761202053 @default.
• W3048060527 cites W2763751953 @default.
• W3048060527 cites W2787301955 @default.
• W3048060527 cites W2794874600 @default.
• W3048060527 cites W2803430447 @default.
• W3048060527 cites W2804159084 @default.
• W3048060527 cites W2864786814 @default.
• W3048060527 cites W2885496269 @default.
• W3048060527 cites W2890220179 @default.
• W3048060527 cites W2891902322 @default.
• W3048060527 cites W2892450953 @default.
• W3048060527 cites W2900391822 @default.
• W3048060527 cites W2901262057 @default.
• W3048060527 cites W2901478468 @default.
• W3048060527 cites W2904940919 @default.
• W3048060527 cites W2905241205 @default.
• W3048060527 cites W2905654445 @default.
• W3048060527 cites W2911603890 @default.
• W3048060527 cites W2947470081 @default.
• W3048060527 cites W2949232578 @default.
• W3048060527 cites W2984618566 @default.
• W3048060527 cites W3004183788 @default.
• W3048060527 cites W3005561109 @default.
• W3048060527 cites W3024103680 @default.
• W3048060527 cites W4231802818 @default.
• W3048060527 cites W4254055155 @default.
• W3048060527 doi "https://doi.org/10.1177/1060028020948165" @default.
• W3048060527 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32762363" @default.
• W3048060527 hasPublicationYear "2020" @default.
• W3048060527 type Work @default.
• W3048060527 sameAs 3048060527 @default.
• W3048060527 citedByCount "6" @default.
• W3048060527 countsByYear W30480605272021 @default.
• W3048060527 countsByYear W30480605272022 @default.
• W3048060527 countsByYear W30480605272023 @default.
• W3048060527 crossrefType "journal-article" @default.
• W3048060527 hasAuthorship W3048060527A5020006994 @default.
• W3048060527 hasAuthorship W3048060527A5029013002 @default.
• W3048060527 hasAuthorship W3048060527A5065535291 @default.
• W3048060527 hasAuthorship W3048060527A5073018865 @default.
• W3048060527 hasConcept C121608353 @default.
• W3048060527 hasConcept C126322002 @default.
• W3048060527 hasConcept C143998085 @default.
• W3048060527 hasConcept C177713679 @default.
• W3048060527 hasConcept C203014093 @default.
• W3048060527 hasConcept C2776694085 @default.
• W3048060527 hasConcept C2777701055 @default.
• W3048060527 hasConcept C2778020697 @default.
• W3048060527 hasConcept C2778461978 @default.
• W3048060527 hasConcept C2780775027 @default.
• W3048060527 hasConcept C2780850621 @default.
• W3048060527 hasConcept C2909962599 @default.
• W3048060527 hasConcept C3875195 @default.

• next